You are viewing the site in preview mode
Skip to main content
|
Parameter
|
Healthy subjects group (%)
|
ESRD group (%)
|
|---|
|
Number of subjects
|
20
|
16
|
|
Males
|
12/20 (60)
|
10/16 (63)
|
|
Paired measurements (baseline and follow-up)
|
20/20 (100)
|
15/16 (94)
|
|
Age (years)
|
45 ± 12
|
63 ± 16***
|
|
Weight (kg)
|
77 ± 10
|
78 ± 21
|
|
Height (m)
|
1.74 ± 0.10
|
1.70 ± 0.10
|
|
SBP (mmHg)
|
118 ± 12
|
142 ± 24**
|
|
DBP (mmHg)
|
71 ± 9
|
67 ± 11
|
|
Smoking (last 6 months)
|
0 (0)
|
0 (0)
|
|
Diabetes
|
0 (0)
|
6/16 (38)
|
|
Hypertension
|
0 (0)
|
12/16 (75)
|
|
Cardiovascular disease (coronary artery disease, heart failure, stroke, TIA, PVD)
|
0 (0)
|
8/16 (50)
|
|
AVF
|
0 (0)
|
12/16 (75)
|
|
Previous renal transplant
|
0 (0)
|
2/16 (13)
|
|
Anti-hypertensive medication
|
0 (0)
|
12/16 (75)
|
-
AVF arteriovenous fistula, DBP diastolic blood pressure, ESRD end-stage renal disease, MI myocardial infarction, PVD peripheral vascular disease, SBP systolic blood pressure, TIA transient ischemic attack
- **p < 0.01; ***p < 0.001
